Role of epilepsy surgery in refractory status epilepticus in children

Sujit A Jagtap1, Nilesh Kurwale2, Sandeep Patil2

  • 1Bharati Vidyapeeth Medical College, Pune, India; Deenanath Mangeshkar Hospital and Research Centre, Pune, India.

Epilepsy Research
|September 2, 2021
PubMed

Insights

Emergency epilepsy surgery (ES) effectively treats refractory status epilepticus (SE) in children with structural brain abnormalities when medical treatments fail. This study shows positive outcomes for pediatric patients undergoing ES for intractable SE.

Area of Science:

  • Pediatric Neurology
  • Neurosurgery
  • Epileptology

Background:

  • Status epilepticus (SE) is a critical neurological emergency, with a significant portion of patients developing refractory SE (RSE) unresponsive to standard treatments.
  • The efficacy of epilepsy surgery (ES) for RSE remains under-investigated, with limited evidence from case reports and small series.
  • Understanding the clinical presentation, imaging findings, and outcomes of RSE patients undergoing ES is crucial for treatment planning.

Purpose of the Study:

  • To evaluate the effectiveness of emergency epilepsy surgery (ES) in children with refractory status epilepticus (RSE).
  • To analyze the clinical characteristics, neuroimaging findings, and surgical outcomes in pediatric patients with RSE undergoing ES.
  • To determine the suitability of ES as a treatment option for pediatric RSE unresponsive to medical management.

Main Methods:

  • Retrospective analysis of pediatric patients diagnosed with SE who did not respond to escalating medical therapy.
  • Inclusion criteria: Patients with SE, failure of medical treatment (including pharmacological suppression), and subsequent ES.
  • Surgical procedures included hemispherotomy, focal cortical dysplasia resection, and hemispheric disconnection.

Main Results:

  • Ten children (7 boys, 3 girls; age 6 months–14 years) with RSE underwent emergency ES.
  • Underlying pathologies included hemimegalencephaly, focal cortical dysplasia, Rasmussen's encephalitis, and porencephalic cysts.
  • Nine out of ten patients achieved excellent seizure control (Engel I outcome), with one patient showing significant improvement (Engel IIIa) at a mean follow-up of 31 months.

Conclusions:

  • Emergency epilepsy surgery is a viable and effective therapeutic strategy for pediatric refractory status epilepticus in cases with identifiable structural brain lesions.
  • Children with RSE and focal or hemispheric abnormalities on MRI, correlating with clinical and/or EEG findings, are strong candidates for surgical intervention.
  • ES can lead to significant seizure reduction or elimination in pediatric RSE patients refractory to medical treatments.
Abstract

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
376
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
696
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
596
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
813
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
278
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
535